New Delhi: Datwyler, the Swiss-based leading industrial supplier that offers state-of-the-art solutions for drug packaging and medical devices has announced that the expansion of its plant in Pune will be completed by end of 2017 and first samples will be supplied in July 2018.
The facility underlines the company’s commitment to India and acknowledges the country’s role in the global pharmaceutical market. The expanded facility will manufacture according to the First Line concept, making India the first market in APAC region to incorporate this standard.
The facility plays a substantial part in Datwyler’s efforts to cater to regional and global markets. Once the production site is fully operational, the facility will cover approximately 58,000 square feet and will create up to 500 jobs, which will be staffed by members of the local community.
Set against the background of the ever-evolving requirements for drug packaging, Datwyler provides a unique range of future-proof health care sealing solutions and services for primary and secondary packaging. This includes the most advanced elastomer formulations, proprietary coatings, sterilization options, and aluminium seals for high-efficiency production lines, which not only meet the demands of current pharma trends, but go beyond them. In India, Datwyler’s core business consists of container closures. Manufacturing close to four billion components for vials, pre-filled syringes, and diagnostic devices per year, the Pune facility plays an increasingly strategic role for the company.
Datwyler India’s upcoming facility in Pune is expected to create about 500 jobs by the end of 2018, majority to be staffed with members of the local community. Expansion of facility incorporates First Line – the manufacturing concept for high-quality elastomer components. Datwyler presents its product portfolio and new health care offering at the CPhI India 2017.
